Monopar Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MNPR and other ETFs, options, and stocks.About MNPR
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages.
MNPR Key Statistics
Stock Snapshot
As of today, Monopar Therapeutics(MNPR) shares are valued at $55.59. The company's market cap stands at 371.48M, with a P/E ratio of -16.14.
During the trading session on 2026-03-05, Monopar Therapeutics(MNPR) shares reached a daily high of $55.72 and a low of $54.22. At a current price of $55.59, the stock is +2.5% higher than the low and still -0.2% under the high.
Trading volume for Monopar Therapeutics(MNPR) stock has reached 76.91K, versus its average volume of 184.77K.
Over the past 52 weeks, Monopar Therapeutics(MNPR) stock has traded between a high of $105.00 and a low of $26.06.
Over the past 52 weeks, Monopar Therapeutics(MNPR) stock has traded between a high of $105.00 and a low of $26.06.
Analyst ratings
100%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.